Dunsire Deborah Insider Trades

Insider Trading History

Track insider trading activity for Dunsire Deborah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.24M 38,566 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 21,809 shares
$25.80
$32.03
Mckesson
Mckesson MCK
Director
Holding Value $242k 301 shares
Last Trade
Jul 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$215k 301 shares
$714.92
$803.37
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $987k 30,815 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$376k 10,787 shares
$34.84
$32.03
Mckesson
Mckesson MCK
Director
Holding Value $280k 349 shares
Last Trade
Jul 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$215k 349 shares
$617.02
$803.37
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $803k 25,075 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 9,900 shares
$37.42
$32.03
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0.6 6,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 6,000 shares
$5.30
$0.00
Mckesson
Mckesson MCK
Director
Holding Value $45k 56 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1k 56 shares
$573.16
$803.37
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.4k 4,000 shares
$5.10
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.2 12,000 shares
Last Trade
Jun 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.4k 4,000 shares
$5.10
$0.00
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $632k 19,730 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$368k 7,110 shares
$51.82
$32.03
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0.6 6,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 6,000 shares
$3.70
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.2 12,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 20,000 shares
$0.73
$0.00
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $200k 6,245 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378k 6,245 shares
$60.57
$32.03
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.75 17,500 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 17,500 shares
$0.78
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.5 35,000 shares
Last Trade
Sep 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 35,000 shares
$5.28
$0.00
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Director
Holding Value $0 0 shares
Last Trade
Jul 21, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.67M 14,629 shares
$182.50
$182.50
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $403k 12,570 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 4,125 shares
$93.20
$32.03
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $334k 10,425 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 6,800 shares
$76.58
$32.03
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Director
Holding Value $2.21M 12,134 shares
Last Trade
May 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 4,409 shares
$100.92
$182.50
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $252k 7,875 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$470k 8,000 shares
$58.74
$32.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up